Literature DB >> 25243359

Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden.

J Westman1, K Wahlbeck, T M Laursen, M Gissler, M Nordentoft, J Hällgren, M Arffman, U Ösby.   

Abstract

OBJECTIVE: To analyse mortality and life expectancy in people with alcohol use disorder in Denmark, Finland and Sweden.
METHOD: A population-based register study including all patients admitted to hospital diagnosed with alcohol use disorder (1,158,486 person-years) from 1987 to 2006 in Denmark, Finland and Sweden.
RESULTS: Life expectancy was 24-28 years shorter in people with alcohol use disorder than in the general population. From 1987 to 2006, the difference in life expectancy between patients with alcohol use disorder and the general population increased in men (Denmark, 1.8 years; Finland, 2.6 years; Sweden, 1.0 years); in women, the difference in life expectancy increased in Denmark (0.3 years) but decreased in Finland (-0.8 years) and Sweden (-1.8 years). People with alcohol use disorder had higher mortality from all causes of death (mortality rate ratio, 3.0-5.2), all diseases and medical conditions (2.3-4.8), and suicide (9.3-35.9).
CONCLUSION: People hospitalized with alcohol use disorder have an average life expectancy of 47-53 years (men) and 50-58 years (women) and die 24-28 years earlier than people in the general population.
© 2014 The Authors. Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Scandinavia; alcoholism; epidemiology; mortality

Mesh:

Year:  2014        PMID: 25243359      PMCID: PMC4402015          DOI: 10.1111/acps.12330

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


Significant outcomes

People with alcohol use disorder have 24–28 years shorter life expectancy than the general population in the Nordic countries. Alcohol use disorder is a major public health problem that causes many years of lost life, even in countries with restrictive alcohol consumption policies.

Limitations

A major limitation of the present study was the inclusion only of patients with alcohol use disorder from inpatient care, which may have caused selection bias of patients with the most severe health problems. The study was register-based and lacked clinical data about treatment and adherence. Alcohol consumption per capita was determined from aggregate data and not from alcohol exposure for individuals.

Introduction

Alcohol use disorder (AUD) is a major cause of morbidity and mortality (1). People with AUD have among the highest all-cause mortality of all people who receive treatment for mental disorders (2, 3). A meta-analysis that included 81 observational studies from many countries showed that people with AUD have three-fold higher mortality in men and four-fold higher mortality in women than the general population (4). In all people who have AUD, mortality is relatively higher in women, younger people and people in treatment for addiction (4). However, comprehensive mortality data over time of patients with AUD are not available from Nordic countries. Increased alcohol consumption is associated with increased disease burden, accidents, and social problems (4, 5). In response to these effects, alcohol policies were created in Nordic countries (Sweden, Norway, Denmark, Finland and Iceland) to promote a decrease in alcohol consumption and restrict alcohol availability. The governments of all Nordic countries except Denmark have a monopoly of alcohol retail. However, after joining the European Union in 1995, Finland and Sweden shifted from a highly restrictive to a more liberal alcohol policy. The price of alcohol was reduced by tax reduction on alcoholic beverages in Denmark and Finland, abolition of quantitative quotas on alcoholic beverages in Sweden and Finland, and more generous opening hours of alcohol retailers in Sweden. These changes made alcohol more accessible to the public in these countries since 2003. The alcohol control policies of the countries were associated with total alcohol consumption (6, 7); Sweden has the most restrictive, and Denmark has the least restrictive alcohol policies. Frequency of heavy alcohol drinkers and alcohol-related problems are often assumed to depend on the level of alcohol consumption in the general population (7–9). The reliable nationwide health care registers in Denmark, Finland and Sweden provide a unique opportunity to study mortality in people diagnosed with AUD.

Aims of the study

The purpose of this study was to evaluate mortality and life expectancy in people who had AUD in Denmark, Finland and Sweden between 1987 and 2006.

Material and methods

Study populations

National health registers from Denmark, Finland and Sweden were used to follow the entire population, approximately 20 million people, aged 15 years or above, in these three countries and identify all people who were admitted to hospital because of AUD as the primary or secondary diagnosis during 20 years (January 1, 1987 to December 31, 2006). Data about patients were retrieved from the national hospital discharge registers in each country. In Denmark, the data about patients were retrieved from the Psychiatric Care Register and the Hospital Discharge Register for medical care. In Finland and Sweden, the Hospital Discharge Registers, which contained information about medical and psychiatric care, were used. The hospital register information was linked to the national registers about causes of death in each country to retrieve data about date and cause of death. Data about alcohol consumption per capita were collected from an international database (6). Follow-up started on the date of first hospital admission for AUD. Each person was followed from the day of first hospital admission until death or the end of a 5-year period to estimate time trends with a sufficient number of deaths; therefore, a person could be counted in more than one time period if readmitted during a different period. For analysis of time trends, the 20-year observation period was divided into 5-year periods: 1987–1991, 1992–1996, 1997–2001 and 2002–2006. Ethical approval was obtained from the regional ethics committee in Gothenburg. The data-keeping authorities from each country gave permission to use health register data in this study.

Definitions

The diagnosis of AUD (mental and behavioural disorders due to alcohol use) was defined according to the World Health Organization classification system (International Classification of Diseases [ICD]): ICD-8, codes 291, 303; ICD-9, codes 291, 303, 305A; ICD-10, codes F10.0 to F10.9 (10–12). Causes of death were defined according to the classification as (1) all-cause mortality (ICD-8, codes 001 to E999; ICD-9, codes 001 to E999; ICD-10, codes A00 to Y98); (2) death from diseases and medical conditions (ICD-8, codes 001 to 796; ICD-9, codes 001 to 799; ICD-10, codes A00 to R99); (3) suicide (ICD-8, codes E950 to E959; ICD-9, codes E950 to E959; ICD-10, codes X60 to 84); and (4) external causes of death other than suicide (ICD-8, codes E800 to E999, excluding codes E950 to E959; ICD-9, codes E800 to E999, excluding codes E950 to E959; ICD-10, codes V01 to Y98, excluding codes X60 to 84) (10–12). Alcohol consumption was defined as the national average of registered amount of alcohol consumed (litres of pure alcohol) per capita aged ≥15 years during a calendar year. The aggregate indicator from taxation data included consumption for the entire population based on production, import, export and sales (6).

Statistical analysis

The study population for each country was stratified into 5 age groups (15–29 years; 30–44 years; 45–59 years; 60–74 years; ≥75 years), and frequency of mortality was calculated for each group. Person-years and number of deaths were determined for each age group and 5-year period. Standardized mortality per 100 000 person-years was calculated for each country and standardized using Nordic population data for the year 2000 (13). Mortality rate ratios were calculated by taking standardized mortality rate in people with AUD divided by standardized mortality rate in general population. We calculated life expectancy for people with AUD aged ≥15 years, stratified by sex, using Wiesler method with 1-year age stratification (14). Life expectancy for each of the 5-year periods was determined. Population life expectancy data for each country, calculated and published by the World Health Organization (6), were used for population comparisons. The difference in life expectancy was calculated by taking life expectancy in general population minus life expectancy in people with AUD. Data from national registers in the Nordic countries include all individuals and are not samples. Therefore, confidence intervals (CI) are not relevant.

Results

Alcohol use disorder: incidence and associated mortality

In Denmark, the number of men and women hospitalized because of AUD was similar for the 5-year periods from 1987 to 2001 but increased for 2002 to 2006 (Table 1). In Finland, the number of men and women with AUD increased from 1987 to 2001 and remained unchanged for 2002 to 2006. In Sweden, the number of men with AUD decreased and the number of women with AUD increased from 1987 to 2006 (Table 1).
Table 1

Alcohol use disorder and associated mortality in Denmark, Finland and Sweden from 1987 to 2006

Study periodDenmark
Finland
Sweden
1987–19911992–19961997–20012002–20061987–19911992–19961997–20012002–20061987–19911992–19961997–20012002–2006
Men
 People with AUD
  No. of people32 36829 81831 64639 16327 84532 23241 74840 48951 41149 09743 71546 840
  No. of deaths486650425041699732293465535554587338670554976313
  Person-years84 19276 14275 01193 98163 45267 22395 95290 994143 990134 416114 017119 116
  Mortality per 100 000 person-years578066226720744550825154558159985096498848215300
  Standardized mortality per 100 000 person-years759181427838772063276476619660675855545952455119
 General population
  Standardized mortality per 100 000 person-years188818671704157619772011204520091660152414131294
Women
 People with AUD
  No. of people13 54213 16814 18817 6585428744612 23512 99914 36614 97816 93919 926
  No. of deaths167318271804257943552397611281305133113271585
  Person-years36 07033 46435 09043 73512 09814 84428 13629 50239 48839 87943 15049 649
  Mortality per 100 000 person-years463854605141589735963523346938243305333830753192
  Standardized mortality per 100 000 person-years537957645249574646144381415241344352404037883779
 General population
  Standardized mortality per 100 000 person-years122312421164109711621197119011421046979934891

AUD, alcohol use disorder.

Alcohol use disorder and associated mortality in Denmark, Finland and Sweden from 1987 to 2006 AUD, alcohol use disorder. Mortality was higher in Denmark than Finland or Sweden (Table 1, Figs 1 and 2). Standardized mortality per 100 000 increased during the entire study period in men and women with AUD in Denmark (Table 1). In Finland and Sweden, the standardized mortality per 100 000 decreased in men and women with AUD during the entire study period (Table 1).
Fig 1

Alcohol Use Disorder (AUD) and associated mortality in Denmark, Finland and Sweden from 1987 to 2006. Standardized mortality per 100 000 person-years. Men.

Fig 2

Alcohol use disorder (AUD) and associated mortality in Denmark, Finland and Sweden from 1987 to 2006. Standardized mortality per 100 000 person-years. Women.

Alcohol Use Disorder (AUD) and associated mortality in Denmark, Finland and Sweden from 1987 to 2006. Standardized mortality per 100 000 person-years. Men. Alcohol use disorder (AUD) and associated mortality in Denmark, Finland and Sweden from 1987 to 2006. Standardized mortality per 100 000 person-years. Women.

Life expectancy

Life expectancy in people with AUD was lowest in Denmark and highest in Sweden (Table 2, Figs 3 and 4). In all three countries, life expectancy was longer for women than men, both for people with AUD and the general population (Table 2). In men and women in Denmark, life expectancy for people with AUD and the general population increased during the entire study, and the difference in life expectancy between people with AUD and the general population increased more for men than women (Table 2). In Finland, life expectancy for people with AUD increased more for women than men, and the difference in life expectancy between people with AUD and the general population increased for men but decreased for women during the entire study (Table 2). In Sweden, life expectancy for people with AUD and the general population increased in men and women, and the difference in life expectancy between people with AUD and the general population increased in men but decreased in women during the entire study (Table 2).
Table 2

Life expectancy of people with alcohol use disorder and people in the general population in Denmark, Finland and Sweden from 1987 to 2006

Life expectancy (years)Denmark
Finland
Sweden
Study period1987–19911992–19961997–20012002–20061987–19911992–19961997–20012002–20061987–19911992–19961997–20012002–2006
Men
 People with AUD46.646.146.747.546.846.446.848.350.351.452.152.7
 General population72.372.874.075.071.773.174.575.875.076.277.378.4
 Difference25.726.727.327.524.926.727.727.524.724.825.225.7
Women
 People with AUD49.849.551.451.252.752.454.356.454.856.557.758.6
 General population77.977.978.779.679.780.781.782.680.781.482.182.7
 Difference28.128.427.328.427.028.327.426.225.924.924.424.1

AUD, alcohol use disorder.

Difference: life expectancy in general population minus life expectancy in people with AUD.

Fig 3

Life expectancy of people with alcohol use disorder (AUD) and people in the general population in Denmark, Finland and Sweden from 1987 to 2006. Men.

Fig 4

Life expectancy of people with alcohol use disorder (AUD) and people in the general population in Denmark, Finland and Sweden from 1987 to 2006. Women.

Life expectancy of people with alcohol use disorder and people in the general population in Denmark, Finland and Sweden from 1987 to 2006 AUD, alcohol use disorder. Difference: life expectancy in general population minus life expectancy in people with AUD. Life expectancy of people with alcohol use disorder (AUD) and people in the general population in Denmark, Finland and Sweden from 1987 to 2006. Men. Life expectancy of people with alcohol use disorder (AUD) and people in the general population in Denmark, Finland and Sweden from 1987 to 2006. Women.

Age

In all three countries, mortality rate ratios in people with AUD were higher in young age groups. In Denmark, mortality rate ratios increased during the entire study in men and women for most age groups, especially ages 30–59 years (Table 3). In Finland, mortality rate ratios increased during the entire study period in men and women aged 30–44 years. In Sweden, mortality rate ratios increased during the entire study period in men aged 30–74 years and women aged 45–74 years (Table 3).
Table 3

Mortality rate ratio for people with alcohol use disorder compared with people in the general population in Denmark, Finland and Sweden from 1987 to 2006

Mortality rate ratio*Denmark
Finland
Sweden
Study period1987–19911992–19961997–20012002–20061987–19911992–19961997–20012002–20061987–19911992–19961997–20012002–2006
Men
 Age (years)
  15–299.59.18.77.515.121.718.816.89.611.59.210.3
  30–4414.216.419.619.312.713.517.620.714.715.518.518.7
  45–598.81111.613.16.97.06.66.78.49.410.311.4
  60–745.05.35.86.33.13.33.33.64.24.34.65.3
  ≥752.02.22.22.41.51.81.31.32.02.02.02.1
 Cause of death
  All causes4.04.44.64.93.23.23.03.03.53.63.74.0
  All diseases and medical conditions3.74.04.24.62.32.32.32.33.13.13.23.4
  Suicide11.311.613.210.712.013.312.912.39.79.312.612.3
  Other external causes8.69.39.511.512.313.510.011.010.211.411.012.0
Women
 Age (years)
  15–2919.211.07.811.732.441.437.026.318.216.712.412.3
  30–4421.724.324.728.423.925.926.130.919.518.619.719.2
  45–5910.213.013.315.613.912.910.110.710.811.812.311.9
  60–745.66.15.86.94.94.75.56.45.96.36.57.4
  ≥752.01.91.92.41.51.51.51.42.22.12.02.1
 Cause of death
  All causes4.44.64.55.24.03.73.53.64.24.14.14.2
  All diseases and medical conditions3.74.14.04.83.02.62.62.83.63.63.53.6
  Suicide21.422.420.424.92235.535.927.315.923.526.828.5
  Other external causes13.513.413.115.023.820.216.916.317.215.115.515.6

Mortality rate ratio: Standardized mortality rate in people with AUD divided by standardized mortality rate in general population.

Excludes suicides and other external causes.

Other external causes exclude suicides.

Mortality rate ratio for people with alcohol use disorder compared with people in the general population in Denmark, Finland and Sweden from 1987 to 2006 Mortality rate ratio: Standardized mortality rate in people with AUD divided by standardized mortality rate in general population. Excludes suicides and other external causes. Other external causes exclude suicides.

Cause of death

In all three countries, people with AUD had higher mortality from all causes of death (Figs 5 and 6), all diseases and medical conditions, and suicide, than people in the general population (Table 3). In Denmark, mortality rate ratios in people with AUD increased from 1987 to 2006 from all diseases and medical conditions; mortality rate ratio from suicide was increased only in women during 2002 to 2006 (Table 3). In Finland, mortality rate ratios from all causes of death decreased during the entire study in both men and women; mortality rate ratios from all diseases and medical conditions were unchanged during the entire study for men and women, and mortality rate ratios from suicide increased in women but not men (Table 3). In Sweden, mortality rate ratios from all causes of death increased in men but was unchanged in women during the entire study; mortality rate ratio from suicide increased in both men and women (Table 3).
Fig 5

Mortality rate ratio for people with alcohol use disorder compared with people in the general population in Denmark, Finland and Sweden from 1987 to 2006. Men.

Fig 6

Mortality rate ratio for people with alcohol use disorder compared with people in the general population in Denmark, Finland and Sweden from 1987 to 2006. Women.

Mortality rate ratio for people with alcohol use disorder compared with people in the general population in Denmark, Finland and Sweden from 1987 to 2006. Men. Mortality rate ratio for people with alcohol use disorder compared with people in the general population in Denmark, Finland and Sweden from 1987 to 2006. Women.

Alcohol consumption

During the entire study, registered alcohol consumption per capita was highest in Denmark and lowest in Sweden (Fig.7). In Denmark, registered alcohol consumption per capita decreased slightly after the year 2002. In Finland, registered alcohol consumption per capita peaked in the time period 2002–2006 in connection with an alcohol tax reduction. In Sweden, registered alcohol consumption per capita decreased slightly in the 90s and increased thereafter.
Fig 7

Registered total alcohol consumption in litres pure alcohol per capita in Denmark, Finland and Sweden from 1987 to 2006.

Registered total alcohol consumption in litres pure alcohol per capita in Denmark, Finland and Sweden from 1987 to 2006.

Discussion

Main findings

In this study, our main finding was a 24- to 28-year shorter life expectancy in people with AUD compared with the general population. Mortality associated with AUD was sex-dependent; men with AUD in all three countries had over time an increased difference in life expectancy, but women with AUD in Finland and Sweden (not Denmark) had a decreased difference in life expectancy. The changes in mortality and life expectancy during the study were most negative in Denmark and least negative in Sweden.

Strengths and limitations

A major strength of this study was the comparison of life expectancy and mortality in all people who had AUD diagnosed in three Nordic countries with different alcohol policies and patterns of alcohol consumption. The availability of nationwide health registers enabled us to follow the entire study population. The large population size (all people treated for AUD from three countries) provided highly reliable data. Much time and effort was invested in quality assurance of statistical analytical techniques, which made the data comparable between the different countries. A major limitation of this study was the inclusion of patients from inpatient care only, which may have caused selection bias towards AUD patients with the most severe health problems. Patients with AUD who had only outpatient care were not included. The study was register-based and lacked clinical data about the type of treatment and adherence. In addition to disease prevalence in the population, patterns of hospitalization data including clinical diagnoses may be affected by other factors that were not analysed, such as changes in the number of hospital beds available, changes in hospital remuneration policies, and differences in clinical indications for hospital treatment. A common shortcoming in register studies is that they rarely can provide satisfactory answers on why the mortality is high or whether its decrease is due to policy changes, improved care or merely administrative decisions (15), although they can hint at the answer and provide directions (15, 16). Another study limitation was that alcohol consumption per capita was determined from aggregate data and not from alcohol exposure for individuals. However, the World Health Organization data used in this study were supported by similar results from population surveys in Denmark, Finland and Sweden (17–19). In the aggregate data, neither age- nor sex-specific alcohol consumption data were available. The results based on aggregated data were exploratory and may not be used to draw definitive causative conclusions. In addition, data about illegal alcohol production and individual cross-border import were not included in the national statistics (6) and could not be evaluated in this study.

Life expectancy and mortality

The difference in life expectancy between people with AUD and the general population during the study increased in men in all three countries, decreased in women in Finland and Sweden, and was unchanged in women in Denmark (Table 2). However, the number of women hospitalized because of AUD increased during the study in all three countries (Table 1), consistent with documented increase in alcohol consumption in women (13). In addition, there has been a decrease in the perceived stigma associated with seeking treatment for AUD (20, 21). Therefore, diagnosis and treatment of AUD may be more common in women currently than 20 years ago. Nevertheless, only 1 in 3 people with AUD seek treatment (21). This study showed that people with AUD had a four-fold greater risk of premature death than people in the general population, and people with AUD died on average 24–28 years earlier than people in the general population. Previous studies showed the mortality risk to be two- to six-fold greater in people with AUD (4, 22). In this study, people with AUD had a greater risk of death from all diseases and medical conditions, suicide, and other external causes of death, than people in the general population, consistent with findings from previous studies (2–4, 22, 23). In men, the difference in mortality between patients with AUD and the general population increased more in Denmark and Finland than Sweden. These differences may be associated with the overall level of alcohol consumption, which is highest in Denmark and lowest in Sweden. The difference in mortality between people with AUD and the general population was smaller for both men and women in all study periods in Sweden than Denmark or Finland (Table 2). The number of deaths among women increased in all three countries during the study period, due to increasing numbers of women diagnosed with AUD in all countries, although standard morality ratios did not increase. The alcohol control policies of the countries are associated with total alcohol consumption; Sweden had the most restrictive, and Denmark had the least restrictive alcohol policies. Other studies have shown that the negative effects of the increased availability of alcohol in Finland mainly occurred in people with AUD (24–27). For example, in Finland, deaths from liver disease increased by 30% and alcohol-related sudden deaths increased by 17% after changes in alcohol regulations in 2004 (27–29).

Clinical implications

Findings from the present study show that AUD in the Nordic countries is associated with substantially increased mortality, even though alcohol control policies are restrictive compared with other countries. What might be important to add to the general restrictive alcohol policies would be selective efforts aimed at high alcohol consumers, to achieve preventive effects in terms of reducing the rate of high consumers converting to AUD. In this field, a wider focus is necessary including testing new preventive efforts, with the aim of reducing alcohol-related harm in people with AUD. In addition the somatic care of people with AUD should be substantially improved. In summary, the present study of the entire populations of Denmark, Finland and Sweden showed that people hospitalized with AUD had an average life expectancy of 47–53 years for men and 50–58 years for women. People hospitalized with AUD had a 24- to 28-year shorter life expectancy than the general population. During the study, the difference in life expectancy between people with AUD and the general population increased in men but not in women. Mortality and life expectancy were associated with total alcohol consumption in the three countries. Furthermore, the comprehensive population data confirmed that AUD is a major public health problem that causes many years of lost life, also in countries with restrictive alcohol consumption policies.
  18 in total

1.  Do consequences of a given pattern of drinking vary by socioeconomic status? A mortality and hospitalisation follow-up for alcohol-related causes of the Finnish Drinking Habits Surveys.

Authors:  P Mäkelä; T Paljärvi
Journal:  J Epidemiol Community Health       Date:  2008-08       Impact factor: 3.710

2.  An evaluation of the impact of a large reduction in alcohol prices on alcohol-related and all-cause mortality: time series analysis of a population-based natural experiment.

Authors:  Kimmo Herttua; Pia Mäkelä; Pekka Martikainen
Journal:  Int J Epidemiol       Date:  2009-12-07       Impact factor: 7.196

Review 3.  Alcohol use disorders and mortality: a systematic review and meta-analysis.

Authors:  Michael Roerecke; Jürgen Rehm
Journal:  Addiction       Date:  2013-05-29       Impact factor: 6.526

Review 4.  [Alcohol consumption by middle-aged and elderly Danes from 1987 to 2003].

Authors:  Christina Bjørk; Mathilde Vinther-Larsen; Lau Caspar Thygesen; Ditte Johansen; Morten N Grønbaek
Journal:  Ugeskr Laeger       Date:  2006-09-25

5.  "A disease like any other"? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence.

Authors:  Bernice A Pescosolido; Jack K Martin; J Scott Long; Tait R Medina; Jo C Phelan; Bruce G Link
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

6.  Alcohol tax cuts and increase in alcohol-positive sudden deaths: a time-series intervention analysis.

Authors:  Anna Koski; Reino Sirén; Erkki Vuori; Kari Poikolainen
Journal:  Addiction       Date:  2007-03       Impact factor: 6.526

7.  Deaths from natural causes in people with mental illness: a cohort study.

Authors:  Urara Hiroeh; Navneet Kapur; Roger Webb; Graham Dunn; Preben Bo Mortensen; Louis Appleby
Journal:  J Psychosom Res       Date:  2008-03       Impact factor: 3.006

8.  Changes in alcohol-related mortality and its socioeconomic differences after a large reduction in alcohol prices: a natural experiment based on register data.

Authors:  Kimmo Herttua; Pia Mäkelä; Pekka Martikainen
Journal:  Am J Epidemiol       Date:  2008-08-20       Impact factor: 4.897

9.  Public health indicators for the EU: the joint action for ECHIM (European Community Health Indicators & Monitoring).

Authors:  Marieke Verschuuren; Mika Gissler; Katri Kilpeläinen; Antti Tuomi-Nikula; Ari-Pekka Sihvonen; Jürgen Thelen; Rita Gaidelyte; Silvia Ghirini; Nils Kirsch; Remigijus Prochorskas; Emanuele Scafato; Pieter Kramers; Arpo Aromaa
Journal:  Arch Public Health       Date:  2013-05-30

10.  Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden.

Authors:  Merete Nordentoft; Kristian Wahlbeck; Jonas Hällgren; Jeanette Westman; Urban Osby; Hassan Alinaghizadeh; Mika Gissler; Thomas Munk Laursen
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more
  32 in total

1.  The costs of hazardous alcohol consumption in Germany.

Authors:  Tobias Effertz; Frank Verheyen; Roland Linder
Journal:  Eur J Health Econ       Date:  2016-08-20

2.  Effects of high alcohol intake, alcohol-related symptoms and smoking on mortality.

Authors:  John B Whitfield; Andrew C Heath; Pamela A F Madden; J George Landers; Nicholas G Martin
Journal:  Addiction       Date:  2017-09-18       Impact factor: 6.526

3.  Excess mortality in a cohort of Brazilian patients with a median follow-up of 11 years after the first psychiatric hospital admission.

Authors:  Paulo Rossi Menezes; Cristina Marta Del-Ben; Daiane Leite da Roza; Marcos Gonçalves de Rezende; Régis Eric Maia Barros; João Mazzoncini de Azevedo-Marques; Jair Lício Ferreira Santos; Lilian Cristina Correia Morais; Carlos Eugenio de Carvalho Ferreira; Bernadette Cunha Waldvogel
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-05-31       Impact factor: 4.328

4.  Alcohol use disorder is associated with DNA methylation-based shortening of telomere length and regulated by TESPA1: implications for aging.

Authors:  Jeesun Jung; Daniel L McCartney; Josephin Wagner; Daniel B Rosoff; Melanie Schwandt; Hui Sun; Corinde E Wiers; Luana Martins de Carvalho; Nora D Volkow; Rosie M Walker; Archie Campbell; David J Porteous; Andrew M McIntosh; Riccardo E Marioni; Steve Horvath; Kathryn L Evans; Falk W Lohoff
Journal:  Mol Psychiatry       Date:  2022-06-15       Impact factor: 15.992

5.  Deep brain stimulation of the nucleus accumbens in the treatment of severe alcohol use disorder: a phase I pilot trial.

Authors:  Benjamin Davidson; Peter Giacobbe; Tony P George; Sean M Nestor; Jennifer S Rabin; Maged Goubran; Alexander J Nyman; Anusha Baskaran; Ying Meng; Christopher B Pople; Simon J Graham; Fred Tam; Clement Hamani; Nir Lipsman
Journal:  Mol Psychiatry       Date:  2022-07-21       Impact factor: 13.437

Review 6.  Ethical and allocation issues in liver transplant candidates with alcohol related liver disease.

Authors:  Mai Sedki; Aijaz Ahmed; Aparna Goel
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

7.  Alcohol Use Disorder and Mortality Across the Lifespan: A Longitudinal Cohort and Co-relative Analysis.

Authors:  Kenneth S Kendler; Henrik Ohlsson; Jan Sundquist; Kristina Sundquist
Journal:  JAMA Psychiatry       Date:  2016-06-01       Impact factor: 21.596

8.  Mortality Among Persons With Obsessive-Compulsive Disorder in Denmark.

Authors:  Sandra M Meier; Manuel Mattheisen; Ole Mors; Diana E Schendel; Preben B Mortensen; Kerstin J Plessen
Journal:  JAMA Psychiatry       Date:  2016-03       Impact factor: 21.596

9.  Measuring Substance-Related Disorders Using Canadian Administrative Health Databanks: Interprovincial Comparisons of Recorded Diagnostic Rates, Incidence Proportions and Mortality Rate Ratios.

Authors:  Christophe Huỳnh; Steve Kisely; Louis Rochette; Éric Pelletier; Kenneth B Morrison; Shelley Li; Gareth Hopkin; Mark Smith; Charles Burchill; Elizabeth Lin; Mark Asbridge; Didier Jutras-Aswad; Alain Lesage
Journal:  Can J Psychiatry       Date:  2021-09-27       Impact factor: 5.321

10.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin; P M Haddad; I N Ferrier; J K Aronson; Trh Barnes; A Cipriani; D R Coghill; S Fazel; J R Geddes; H Grunze; E A Holmes; O Howes; S Hudson; N Hunt; I Jones; I C Macmillan; H McAllister-Williams; D R Miklowitz; R Morriss; M Munafò; C Paton; B J Saharkian; Kea Saunders; Jma Sinclair; D Taylor; E Vieta; A H Young
Journal:  J Psychopharmacol       Date:  2016-03-15       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.